Correlation Between Oncolytics Biotech and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Armata Pharmaceuticals, you can compare the effects of market volatilities on Oncolytics Biotech and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Armata Pharmaceuticals.
Diversification Opportunities for Oncolytics Biotech and Armata Pharmaceuticals
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Oncolytics and Armata is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Armata Pharmaceuticals
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Armata Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.94 times less risky than Armata Pharmaceuticals. The stock trades about -0.34 of its potential returns per unit of risk. The Armata Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 232.00 in Armata Pharmaceuticals on August 28, 2024 and sell it today you would lose (3.00) from holding Armata Pharmaceuticals or give up 1.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Oncolytics Biotech |
| Armata Pharmaceuticals |
Oncolytics Biotech and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Armata Pharmaceuticals
The main advantage of trading using opposite Oncolytics Biotech and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |